Wound Care (Pharmacies) - Benelux

Benelux

Highlights

Revenue in the Wound Care market is projected to reach US$61.50m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.02%, resulting in a market volume of US$61.55m by 2029.
In global comparison, most revenue will be generated United States (US$1.04bn in 2024).
In relation to total population figures, per person revenues of US$2.05 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Wound Care (Pharmacies) market in Benelux is experiencing significant growth due to changing customer preferences and emerging trends in the market. Customer preferences in the Wound Care (Pharmacies) market in Benelux are shifting towards products that offer convenience and ease of use. Customers are increasingly looking for wound care products that can be easily applied at home, without the need for medical assistance. This preference is driven by the growing awareness of self-care and the desire to reduce healthcare costs. Additionally, customers are seeking products that are gentle on the skin and provide effective wound healing. As a result, there is a growing demand for wound care products that are made from natural and organic ingredients. One of the key trends in the Wound Care (Pharmacies) market in Benelux is the increasing adoption of advanced wound care products. These products offer innovative solutions for wound healing, including the use of technologies such as hydrogels, foam dressings, and negative pressure wound therapy. Advanced wound care products are designed to accelerate the healing process and provide better outcomes for patients. This trend is driven by the growing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, which require specialized care. Another trend in the market is the growing focus on infection control. Healthcare-associated infections are a major concern in wound care, as they can delay the healing process and increase healthcare costs. As a result, there is a growing demand for wound care products that have antimicrobial properties and can prevent infections. This trend is driven by the increasing awareness of the importance of infection control and the need to reduce the risk of complications in wound healing. In addition to changing customer preferences and emerging trends, there are also local special circumstances that are influencing the development of the Wound Care (Pharmacies) market in Benelux. One of these special circumstances is the aging population in the region. The Benelux countries have a high proportion of elderly people, who are more prone to chronic wounds and require specialized wound care products. This demographic factor is driving the demand for wound care products in the region. Furthermore, the healthcare system in Benelux is characterized by a strong emphasis on primary care and community pharmacies. Pharmacies play a crucial role in the provision of wound care products, as they are easily accessible to the general population and provide expert advice on wound care management. This local circumstance is contributing to the growth of the Wound Care (Pharmacies) market in Benelux. Underlying macroeconomic factors, such as the overall economic growth and healthcare expenditure in Benelux, are also driving the development of the Wound Care (Pharmacies) market. The region has a stable and prosperous economy, which supports the demand for healthcare products and services. Additionally, the governments in Benelux countries have implemented policies to promote healthcare access and affordability, which further contributes to the growth of the market. In conclusion, the Wound Care (Pharmacies) market in Benelux is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The market is witnessing a shift towards convenient and advanced wound care products, driven by the desire for self-care and better outcomes. The aging population and the role of pharmacies in the healthcare system are also contributing to the growth of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.